Literature DB >> 22082348

Epigenetic modifications in cancer.

R Kanwal1, S Gupta.   

Abstract

Cancer initiation and progression is controlled by both genetic and epigenetic events. The complexity of carcinogenesis cannot be accounted for by genetic alterations alone but also involves epigenetic changes. Epigenetics refers to the study of mechanisms that alter gene expression without altering the primary DNA sequence. Epigenetic mechanisms are heritable and reversible, and include changes in DNA methylation, histone modifications and small noncoding microRNAs (miRNA). Disruption of epigenetic processes can lead to altered gene function and malignant cellular transformation. Aberrant epigenetic modifications probably occur at a very early stage in neoplastic development, and they are widely described as essential players in cancer progression. Recent advances in epigenetics offer a better understanding of the underlying mechanism(s) of carcinogenesis and provide insight into the discovery of putative cancer biomarkers for early detection, disease monitoring, prognosis, and risk assessment. In this review, we summarize the current literature on epigenetic changes causing genetic alterations that are thought to contribute to cancer, and discuss the potential impact of epigenetics future research.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22082348      PMCID: PMC3590802          DOI: 10.1111/j.1399-0004.2011.01809.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  71 in total

Review 1.  Epigenetic modifications and human disease.

Authors:  Anna Portela; Manel Esteller
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

Review 2.  DNA methylation and human disease.

Authors:  Keith D Robertson
Journal:  Nat Rev Genet       Date:  2005-08       Impact factor: 53.242

Review 3.  Linking DNA methylation and histone modification: patterns and paradigms.

Authors:  Howard Cedar; Yehudit Bergman
Journal:  Nat Rev Genet       Date:  2009-05       Impact factor: 53.242

Review 4.  DNA methylomes, histone codes and miRNAs: tying it all together.

Authors:  Sònia Guil; Manel Esteller
Journal:  Int J Biochem Cell Biol       Date:  2008-09-13       Impact factor: 5.085

5.  Histone modification levels are predictive for gene expression.

Authors:  Rosa Karlić; Ho-Ryun Chung; Julia Lasserre; Kristian Vlahovicek; Martin Vingron
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

Review 6.  Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers.

Authors:  Ping Chi; C David Allis; Gang Greg Wang
Journal:  Nat Rev Cancer       Date:  2010-07       Impact factor: 60.716

Review 7.  DNA methylation of cancer genome.

Authors:  Hoi-Hung Cheung; Tin-Lap Lee; Owen M Rennert; Wai-Yee Chan
Journal:  Birth Defects Res C Embryo Today       Date:  2009-12

8.  MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer.

Authors:  Peter Olson; Jun Lu; Hao Zhang; Anny Shai; Matthew G Chun; Yucheng Wang; Steven K Libutti; Eric K Nakakura; Todd R Golub; Douglas Hanahan
Journal:  Genes Dev       Date:  2009-09-15       Impact factor: 11.361

Review 9.  Oxidative stress, DNA methylation and carcinogenesis.

Authors:  Rodrigo Franco; Onard Schoneveld; Alexandros G Georgakilas; Mihalis I Panayiotidis
Journal:  Cancer Lett       Date:  2008-03-26       Impact factor: 8.679

10.  Impact of 7,8-dihydro-8-oxoguanine on methylation of the CpG site by Dnmt3a.

Authors:  Diana V Maltseva; Alexander A Baykov; Albert Jeltsch; Elizaveta S Gromova
Journal:  Biochemistry       Date:  2009-02-17       Impact factor: 3.162

View more
  134 in total

1.  CpG and methylation-dependent DNA binding and dynamics of the methylcytosine binding domain 2 protein at the single-molecule level.

Authors:  Hai Pan; Stephanie M Bilinovich; Parminder Kaur; Robert Riehn; Hong Wang; David C Williams
Journal:  Nucleic Acids Res       Date:  2017-09-06       Impact factor: 16.971

2.  Base-resolution methylation patterns accurately predict transcription factor bindings in vivo.

Authors:  Tianlei Xu; Ben Li; Meng Zhao; Keith E Szulwach; R Craig Street; Li Lin; Bing Yao; Feiran Zhang; Peng Jin; Hao Wu; Zhaohui S Qin
Journal:  Nucleic Acids Res       Date:  2015-02-26       Impact factor: 16.971

3.  The anti-tumor effects of Mfn2 in breast cancer are dependent on promoter DNA methylation, the P21Ras motif and PKA phosphorylation site.

Authors:  Yufeng Li; Wenyue Dong; Xijin Shan; Hui Hong; Yan Liu; Yankun Liu; Xiaohui Liu; Xiaojun Zhang; Jinghua Zhang
Journal:  Oncol Lett       Date:  2018-03-21       Impact factor: 2.967

Review 4.  Epigenetic mechanisms in anti-cancer actions of bioactive food components--the implications in cancer prevention.

Authors:  B Stefanska; H Karlic; F Varga; K Fabianowska-Majewska; Ag Haslberger
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

5.  Epigenetic field defects in progression to cancer.

Authors:  Carol Bernstein; Valentine Nfonsam; Anil Ramarao Prasad; Harris Bernstein
Journal:  World J Gastrointest Oncol       Date:  2013-03-15

6.  G9a/RelB regulates self-renewal and function of colon-cancer-initiating cells by silencing Let-7b and activating the K-RAS/β-catenin pathway.

Authors:  Shih-Ting Cha; Ching-Ting Tan; Cheng-Chi Chang; Chia-Yu Chu; Wei-Jiunn Lee; Been-Zen Lin; Ming-Tsan Lin; Min-Liang Kuo
Journal:  Nat Cell Biol       Date:  2016-08-15       Impact factor: 28.824

7.  EZH2 inhibition: a promising strategy to prevent cancer immune editing.

Authors:  Ning Kang; Mark Eccleston; Pier-Luc Clermont; Maryam Latarani; David Kingsley Male; Yuzhuo Wang; Francesco Crea
Journal:  Epigenomics       Date:  2020-09-17       Impact factor: 4.778

Review 8.  Epigenetic Alterations in Bladder Cancer.

Authors:  Sima P Porten
Journal:  Curr Urol Rep       Date:  2018-10-24       Impact factor: 3.092

9.  An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice.

Authors:  Mouad Edderkaoui; Chintan Chheda; Badr Soufi; Fouzia Zayou; Robert W Hu; V Krishnan Ramanujan; Xinlei Pan; Laszlo G Boros; Jian Tajbakhsh; Anisha Madhav; Neil A Bhowmick; Qiang Wang; Michael Lewis; Richard Tuli; Aida Habtezion; Ramachandran Murali; Stephen J Pandol
Journal:  Gastroenterology       Date:  2018-08-23       Impact factor: 22.682

10.  Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention.

Authors:  Siddavaram Nagini
Journal:  World J Gastrointest Oncol       Date:  2012-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.